North Carolina House Bill H754

North Carolina 2023-2024 Regular Session

• Introduced: 4/18/23
• Refer: 4/19/23

Caption

Req. Consent to Monetize Protected Hlth Info

Impact

If enacted, HB 754 could significantly change how healthcare providers and other entities handle PHI. It establishes clear requirements for notifying patients regarding the sale or transfer of their health information and requires patients to give their explicit consent. This legislation aims to prevent unauthorized monetization of health data, aligning with growing public demand for stronger privacy protections. It adds a layer of transparency to healthcare operations, which could enhance patient trust in healthcare providers and the healthcare system overall.

Summary

House Bill 754, titled 'Req. Consent to Monetize Protected Health Info,' aims to enhance protections against the use, disclosure, or sale of protected health information (PHI) by requiring covered entities to notify patients prior to any such actions. Specifically, it mandates that covered entities must obtain patients' explicit consent before disclosing their health information outside of routine patient care practices. The bill seeks to bolster the privacy rights of individuals by ensuring they are fully informed about how their personal data is used and shared. This legislation is set to go into effect on January 1, 2024, applying to actions occurring thereafter.

Sentiment

Overall, sentiment surrounding HB 754 appears to be positive among those advocating for patient privacy rights, as it addresses long-standing concerns about data privacy in the healthcare sector. Supporters argue that it empowers patients and protects their sensitive information, reflecting a broader trend towards increased data security and individual rights in the digital age. However, some healthcare stakeholders may have reservations about the potential administrative burdens and implications for data sharing practices, which may require adjustments to existing protocols.

Contention

While the bill has garnered support for its focus on patient consent and privacy, there are potential points of contention regarding its implementation and impact on clinical research. Opponents may argue that the requirements for obtaining consent could hinder the efficiency of research processes that often rely on data sharing. Additionally, the exemption for clinical research might lead to debates over what constitutes an appropriate balance between protecting individual privacy and advancing public health objectives through research. Stakeholders will need to navigate these challenges to ensure the bill achieves its intended protective goals without disrupting essential healthcare services.